why choose us

First received: July 10, 2022

Clinical Trial: The Effect of Dihydroartemisinin in PCOS

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Polycystic Ovary Syndrome

Study Type: Interventional


Official Title: The Evaluation of the Effect of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome

Brief Summary: Artemisinin has been widely used as a first-line antimalarial drug in routine clinical practice. In recent years, it has been reported that Artemisinin also has some significant anti-inflammatory, anti-tumor and immune-modulating effects. The investigators' previous studies discovered that Artemisinin dramatically reduced serum androgen levels and improved poly-cystic ovary syndrome(PCOS) in animals. Preliminary study by the investigators found that artemisinin derivatives are capable of reducing both androgen…

Read more